Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;4(11):563-8.
doi: 10.4103/1947-2714.103315.

Bacteriological and resistance profile in isolates from diabetic patients

Vinita Rawat  1 , Monil Singhai, Ashok Kumar, Pawan Kumar Jha, Rajeev Goyal
Affiliations

Bacteriological and resistance profile in isolates from diabetic patients

Vinita Rawat et al. N Am J Med Sci. 2012 Nov.

Abstract

Background: Diabetes mellitus has become a global epidemic illness and poses a threat for development of resistant bacterial infections.

Aim: This study was aimed to know the bacteriological and resistance profile of isolates obtained from diabetic patients.

Materials and methods: The bacterial isolates obtained from various samples of diabetic patients admitted in medicine department in 6-month period were identified and tested for antibiotic susceptibility. The extended spectrum beta-lactamases (ESβL), AmpC, and metallo-beta-lactamases (MβL) enzymes were detected in gram-negative bacilli. Methicillin, macrolide-lincosamide-streptogramin (MLS), and linezolid resistance in Staphylococcus spp. were detected. High-level aminoglycoside resistance (HLAR) in Enterococcus spp. was also tested.

Results: In all, 38 of 125 diabetic patients (30.4%) had bacterial infection, 18 patients had wound infections, 18 had urinary tract infections (UTIs), and 2 had respiratory tract infections. Escherichia coli among gram-negative bacteria and Staphylococcus aureus among gram-positive bacteria were the predominant pathogens. 32.5% gram-negative bacilli were AmpC producers, 37.5% were MβL producers, and 40% were ESβL producers. Methicillin and MLS resistance was found in 50% and 33.3% isolates of Staphylococcus spp., respectively. HLAR resistance was alarming in Enterococcus spp. Polymyxin among gram-negative bacteria and vancomycin for gram-positive bacteria were the last resort with highest susceptibility rates to treat infections among diabetic patients.

Conclusion: Resistant bacterial infections in diabetic patients are common. The presence of various resistance mechanisms in isolates of our study shows that therapeutic failure can occur if empirical prescription is unsubstantiated.

Keywords: Antibiotic resistance; Diabetes mellitus; Therapeutic failure.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Detection of AmpC and MBL production in E. coli
See this image and copyright information in PMC

References

    1. Devraj S, Goyal R, Jialal I. London: Touch Briefings; 2008. Inflammation, oxidative stress and metabolic syndrome, US endocrinology; pp. 32–7.
    1. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281–8. - PubMed
    1. Marble A, White HJ, Fernald AT. The nature of the lowered resistance to infection in diabetes mellitus. J Clin Invest. 1938;17:423–30. - PMC - PubMed
    1. Zubair M, Abida M, Jamal A. Clinicobacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in North India. Biol Med. 2010;2:22–34.
    1. Luo G, Spellberg B, Gebremariam T, Bolaris M, Lee H, Fu Y, et al. Diabetic murine models for Acinetobacter baumannii infection. J Antimicrob Chemother. 2012;67:1439–45. - PMC - PubMed

LinkOut - more resources